Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.9099
Delayed Data
As of Apr 20
 +0.0007 / +0.08%
Today’s Change
0.72
Today|||52-Week Range
3.20
-10.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues119.9M9.4M13.1M15.9M
 
 
 
 
 
Cost of Goods Sold114.6M5.7M6.1M6.9M
 
 
 
 
 
Depreciation And Amortization2.4M5.0M4.3M3.7M
 
 
 
 
 
 
Operating ExpensesGross Income3.0M-1.3M2.7M5.3M
 
 
 
 
 
General Expenses14.3M27.7M17.6M18.7M
 
 
 
 
 
Research And Development--2.3M1.6M1.5M
 
 
 
 
Total Operating Expenses131.3M38.4M28.0M29.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.4M-29.0M-14.9M-13.4M
 
 
 
 
 
Extraordinary Credit--8.0M11.9M7.1M
 
 
 
 
Extraordinary Charge-2.1M-19.4M-3.4M-4.3M
 
 
 
 
 
Interest Expense On Debt602.0K3.7M2.1M433.0K
 
 
 
 
 
Other Expenses-68.0K-93.0K14.0K-2.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.1M-44.2M-8.6M-13.1M
 
 
 
 
 
Income Taxes-4.7M-13.1M-162.0K-395.0K
 
 
 
 
 
Discontinued Operations-6.7M-1.9M-1.2M521.0K
 
 
 
 
 
Extraordinary Items0.0021.6M1.3M0.00
 
 
 
Net Income-16.1M-33.0M-9.7M-12.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5M1.5M1.8M15.8M
 
 
 
 
 
Shares To Calculate EPS Diluted1.5M1.5M1.8M15.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$10.80-$7.30-$4.59-$0.78
 
 
 
 
 
EPS Diluted-$10.80-$21.32-$5.32-$0.77